ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio Total Assets (Quarterly) : 152.04M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 152.04M |
| March 31, 2026 | 136.68M |
| December 31, 2025 | 152.98M |
| September 30, 2025 | 160.88M |
| June 30, 2025 | 126.17M |
| March 31, 2025 | 130.84M |
| December 31, 2024 | 15.92M |
| September 30, 2024 | 148.99M |
| June 30, 2024 | 157.48M |
| March 31, 2024 | 172.78M |
| December 31, 2023 | 192.09M |
| September 30, 2023 | 215.34M |
| June 30, 2023 | 171.76M |
| March 31, 2023 | 152.40M |
| Date | Value |
|---|---|
| December 31, 2022 | 172.26M |
| September 30, 2022 | 190.47M |
| June 30, 2022 | 211.18M |
| March 31, 2022 | 227.75M |
| December 31, 2021 | 247.88M |
| September 30, 2021 | 261.70M |
| June 30, 2021 | 278.83M |
| March 31, 2021 | 293.66M |
| December 31, 2020 | 168.40M |
| September 30, 2020 | 60.76M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 85.97M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.971M |
| Shareholders Equity (Quarterly) | 142.07M |
| Debt to Equity Ratio | 0.0315 |
| Current Ratio | 21.47 |
| Net Debt Paydown Yield | 0.64% |